EMMA DAVIS: Open Payments
NPI 1598437485 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 53 payments from 13 companies in 2025. Trend: 2023 $450 · 2024 $650 · 2025 $1,226
Food & beverage: $1,146Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $286 |
| Regeneron Healthcare Solutions, Inc. | 10 | $275 |
| UCB, Inc. | 7 | $198 |
| ABBVIE INC. | 5 | $96 |
| PFIZER INC. | 6 | $92 |
| Incyte Corporation | 3 | $72 |
| LEO Pharma Inc. | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| GENZYME CORPORATION | 1 | $39 |
| Amgen Inc. | 1 | $29 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, CIBINQO, OPZELURA, ADBRY, OTEZLA.
Industry payments across FL — which companies pay providers there.
